ScholarIQanswers from OpenAlex & ORCID
Ruzaika Cader
ResearcherPublications, citations & collaboration network
Ruzaika Cader is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ruzaika Cader have?
ScholarIQindexed works
Ruzaika Cader has 3 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ruzaika Cader have?
ScholarIQcitation count
Ruzaika Cader has 13 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ruzaika Cader?
ScholarIQh-index
Ruzaika Cader has an h-index of 2 in OpenAlex.
What is the i10-index of Ruzaika Cader?
ScholarIQi10-index
Ruzaika Cader has an i10-index of 0 in OpenAlex.
What is the OpenAlex record for Ruzaika Cader?
ScholarIQopenalex
The OpenAlex for Ruzaika Cader is on the source record.
What are the most-cited papers on Ruzaika Cader?
ScholarIQmost cited works
A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING)
Lisa Willcocks, Wendi Qian, Ruzaika Cader, Katrina Gatley, Hira Siddiqui, Endurance Tabebisong, Karlena Champion, Andreas Kronbichler, Liz Lightstone, David Jayne, Edward Wilson, Megan Griffith
Advances in primary glomerulonephritis
B. Ellison, Ruzaika Cader, Lisa Willcocks
Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING)
Lisa Willcocks, Wendi Qian, Ruzaika Cader, Katrina Gatley, Hira Siddiqui, Endurance Tabebisong, Karlena Champion, Andreas Kronbichler, Liz Lightstone, David Jayne, Edward Wilson, Megan Griffith